Sanofi (EPA: SAN)
France flag France · Delayed Price · Currency is EUR
90.90
+0.10 (0.11%)
Nov 21, 2024, 4:25 PM CET

Sanofi Company Description

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally.

It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.

In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines.

The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema.

Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer.

Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies.

It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab.

The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

Sanofi
Sanofi logo
Country France
Founded 1994
Industry Drug Manufacturers - General
Sector Healthcare
Employees 86,088
CEO Paul Hudson

Contact Details

Address:
46, avenue de la Grande Armée,
Paris, 75017
France
Phone 33 1 53 77 40 00
Website sanofi.com

Stock Details

Ticker Symbol SAN
Exchange Euronext Paris
Fiscal Year January - December
Reporting Currency EUR
ISIN Number FR0000120578
SIC Code 2834

Key Executives

Name Position
Paul Hudson Chief Executive Officer and Director
François-Xavier Roger Executive Vice President and Chief Financial Officer
Madeleine Roach Executive Vice President and Head of Business Operations
Laurent Gilhodes Principal Accounting Officer and Vice President of Corporate Accounting
Dr. Josephine Fubara Chief Science Officer of Consumer Health Care
Thomas Kudsk Larsen Head of Investor Relations
Dante Beccaria Global Compliance Officer and Vice President
Roy Papatheodorou Executive Vice President and General Counsel
Josep Catlla Head of Communications
Pierre Chancel Senior Vice President of Global Diabetes and Senior Vice President of Global Marketing